Addiction is a global human crisis.
Addiction is a chronic, relapsing condition. It is a disease reaching epidemic proportions – a global human crisis we are committed to addressing.
According to the 2016 World Drug Report, it is estimated that 1 in 20 adults, or a quarter of a billion people worldwide aged 15 to 64, used an illicit drug* in 2014, which is roughly equivalent to the combined populations of France, Germany, Italy and the United Kingdom. In 2010, 3.6 million years of life were lost due to premature death caused by drug use. Opioid dependence contributed most to the burden of the disease, being responsible for 55% of years of life lost due to premature death.
But the global addiction crisis is not restricted to drug use disorders and drug dependence. According to the World Health Organization (WHO), there were approximately 124 million people dependent on alcohol globally (2014), with over 3 million deaths caused by harmful alcohol use each year.
What’s more, addiction doesn’t discriminate. It can affect people from all walks of life. In 2015, according to a Kaiser Health Tracking Poll, more than half (56%) of Americans reported that they had some personal connection to the issue of opioid dependence, saying that they or someone they knew had abused, been addicted to, or died from prescription painkillers.
Global addiction overview
Addiction differs in prevalence and severity in different parts of the world. According to the 2015 National Survey on Drug Use and Health, 2.4 million people suffered from opioid use disorder (1.8m prescription pain reliever, 344,000 heroin, and 241,000 both prescription pain relievers and heroin) in the US, while over 12.4 million adults were alcohol dependent (2014). Our people, culture, expertise and insight, coupled with our innovative technology and stakeholder relationships, mean we are well placed to address patients’ needs around the world. In Canada, as many as 200,000 people were estimated to be addicted to prescription painkillers (2012), while in Europe there were potentially 1.3 million high-risk opioid users, the majority of whom were heroin users (2014). In 2014, Australia ranked as the third highest country worldwide for prescription painkiller misuse per year, and China has a potential unmet patient need – with 7.3 million people estimated to be dependent on opioids and 27 million people dependent on alcohol (2014).
This must change.
Our goal is to medicalize addiction. This starts by partnering with people of influence such as healthcare professionals, policymakers, payers, and the public health community to create an environment of education and options. It starts by breaking down the social barriers so patients can be empowered to seek treatment and providing expanded access to quality treatment for patients all over the world.
The numbers are staggering. The need is clear. That is why we place the patient at the center of our decisions.
For further information and reference view the Indivior Prospectus.